drugset / Trial / NCT00302653
Rasburicase in Tumor Lysis Syndrome
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether rasburicase is effective and safety in correcting hyperuricemia.
Timeline
- Start
- 2006-02
- Primary completion
- 2006-11
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rasburicase | Protein / enzyme biologic | 0.2 mg/kg | — |
Indications
No indication recorded.